InnoCare Pharma Ltd. A (688428.SS) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · China · ISIN CNE100005P56
InnoCare Pharma Ltd. A financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.01 bn CNY | 2.37 bn CNY |
| Gross profit | 871.01 m CNY | 2.18 bn CNY |
| Operating income | -525.78 m CNY | 496.00 m CNY |
| EBIT | -418.81 m CNY | 709.87 m CNY |
| Net income | -440.63 m CNY | 642.47 m CNY |
| Diluted EPS – continuing operations | -0.25 CNY | 0.36 CNY |
Full history since 2020, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About InnoCare Pharma Ltd. A
InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China. The company develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r) chronic lymphocytic leukemia, r/r mantle cell lymphoma, r/r Waldenstrom's macroglobulinemia, r/r marginal zone lymphoma, r/r diffuse large B-cell lymphoma (DLBCL)- MCD, r/r central nervous system lymphoma, combo w/MIL-62, systemic lupus erythematosus, immune thrombocytopenia purpura, multiple sclerosis, and neuromyelitis optica spectrum disorder. It also developing ICP-B02 to treat CD20+B-cell malignancies; ICP-B05 to treat hemato-oncology; ICP-248 to treat chronic lymphocytic leukemia; ICP-332 to treat atopic dermatitis; ICP-488 to treat psoriasis; ICP-538 to treat autoimmune diseases; zurletrectinib (ICP-723) to treat neurotrophic tyrosine receptor kinase fusion positive cancers; ICP-189 to treat non-small cell lung cancer; and ICP-B05 to treat solid tumor. The company has research collaboration and license agreement with Eli Lilly and Company to develop new medicines. InnoCare Pharma Limited was incorporated in 2015 and is headquartered in Beijing, China.
More stocks
- Wuhan Guide Infrared Co Ltd (002414.SZ)
- Amorepacific Corp. (New) (090430.KS)
- ENN Energy Holdings Ltd (2688.HK)
- Huadong Medicine Co Ltd (000963.SZ)
- Compagnie du Cambodge SA (CBDG.PA)
- SICC Co. Ltd. (688234.SS)
- Koninklijke Vopak NV (VPK.AS)
- SBM Offshore NV (SBMO.AS)
- FEDERAL SIGNAL CORP /DE/ (FSS)
- Stockland Corporation Ltd (SGP.AX)
- Konfoong Materials International Co Ltd (300666.SZ)
- MP Materials Corp. / DE (MP)
Not investment advice. All data without warranty, price as of 20.10.2026. Details in the risk notice.